Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Hodl Isabel |

** = Publications listed in SCI/SSCI/Pubmed

2024

Full paper/article (Journal)

** Karbiener, M; Kindle, G; Meyts, I; Seppänen, MRJ; Candotti, F; Kamieniak, M; Ilk, R; Kreil, TR; Seidel, MG, , ESID‐COVID, Consortium Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
J Med Virol. 2024; 96(6):e29738 Doi: 10.1002/jmv.29738
Web of Science PubMed FullText FullText_MUG

 

2023

Full paper/article (Journal)

** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 25(4):105103 Doi: 10.1016/j.micinf.2023.105103 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Full paper/article (Journal)

** Reininghaus, EZ; Manchia, M; Dalkner, N; Bonkat, N; Squassina, A; Hodl, I; Vieta, E; Reif, A; Hajek, T; Landén, M; Correll, CU; Scott, J; Etain, B; Rietschel, M; Bergink, V; Martinez-Cengotitabengoa, M; Kessing, LV; Fagiolini, A; Bauer, M; Goodwin, G; Gonzalez-Pinto, A; Kupka, RW; Schulze, TG; Lagerberg, TV; Yildiz, A; Henry, C; Morken, G; Ritter, P; Nieslen, RE; Licht, RW; Bechdolf, A; Andreassen, OA; Fellendorf, FT Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review.
Eur Neuropsychopharmacol. 2022; 54:90-99 Doi: 10.1016/j.euroneuro.2021.09.001 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Sallegger, C; Hodl, I; Dreo, B; Ihm, VL; Thiel, J; Stradner, M; Fessler, J DISTURBED CELLULAR IMMUNITY FOLLOWING MRNA VACCINATION AGAINST COVID-19 IN PATIENTS WITH B-CELL DEPLETING THERAPY
ANN RHEUM DIS. 2022; 81: 969-970.-EULAR; Kopenhagen, DENMARK;. Doi: 10.1136/annrheumdis-2022-eular.4450 [Poster]
Web of Science FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742 Doi: 10.3389/fimmu.2021.803742 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Full paper/article (Journal)

** Hodl, I; Bosch, P; Dreo, B; Stradner, MH Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome.
Front Immunol. 2020; 11: 576200-576200. Doi: 10.3389/fimmu.2020.576200 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

© Med Uni GrazImprint